Insider Trading February 23, 2026

Entegris CFO Disposes $1.54 Million in Shares Amid Option Exercises and PSU Settlements

Linda LaGorga sold 11,438 shares while also receiving shares from performance awards and option exercises as analysts update outlook after strong Q4 2025 results

By Hana Yamamoto ENTG
Entegris CFO Disposes $1.54 Million in Shares Amid Option Exercises and PSU Settlements
ENTG

Entegris Inc. Chief Financial Officer Linda LaGorga reported a sale of 11,438 shares at $135.00, generating $1.54 million, according to a Form 4 filing. The filing also shows LaGorga received shares from settled performance share units and from exercising employee stock options. The disclosure comes as the stock trades close to its 52-week high and following Entegris' better-than-expected fourth-quarter 2025 results and subsequent analyst price target increases.

Key Points

  • CFO Linda LaGorga sold 11,438 shares at $135.00, totaling $1.54 million, per an SEC Form 4 filing.
  • LaGorga also received 8,840 shares from settlement of performance share units for the 2023-2025 cycle and exercised options for 11,438 shares at $91.63 (value $1,048,063); 2,950 shares were withheld for taxes ($391,376).
  • Entegris posted Q4 2025 results above estimates (EPS $0.70 vs $0.66; revenue $824M vs $811.04M) and saw price target increases from BMO ($148, Outperform) and KeyBanc ($156, Overweight), with first-half guidance suggesting about 4% topline growth.

Entegris Inc. (NASDAQ:ENTG) reported an insider transaction in which Linda LaGorga, the company's senior vice president and chief financial officer, sold 11,438 shares of common stock at $135.00 per share, for proceeds of approximately $1.54 million, according to a Form 4 filing with the Securities and Exchange Commission.

The sale was recorded while shares of the company were trading near a 52-week high of $138.99; at the time referenced in the filing the stock was at $136.54. Entegris has a market capitalization of $20.71 billion and is trading at a price-to-earnings ratio of 87.33.

The SEC filing details additional related transactions affecting LaGorga's holdings. She was issued 8,840 shares at no cost as a result of the settlement of performance share units for the 2023-2025 performance cycle. The filing also shows that LaGorga exercised employee stock options to acquire 11,438 shares at an exercise price of $91.63, representing a total exercised value of $1,048,063.

To satisfy tax obligations associated with these transactions, the filing indicates that 2,950 shares were withheld at a price of $132.67, equal to $391,376.

Separately, the company recently reported fourth-quarter results for fiscal 2025 that topped market expectations. Entegris posted earnings per share of $0.70 versus a projected $0.66, and revenue of $824 million compared with an anticipated $811.04 million. Those results preceded analyst upward revisions to price targets.

BMO Capital raised its price target on Entegris to $148 while maintaining an Outperform rating. KeyBanc Capital Markets increased its target to $156 from $111 and retained an Overweight rating, noting the potential for a material recovery for the company even though initial growth is modest. KeyBanc highlighted first-half guidance pointing to roughly 4% topline growth.

Additional valuation commentary in the filing references InvestingPro analysis, which indicates the stock is currently overvalued relative to its Fair Value. Investors are directed to the Pro Research Report for more detailed valuation insights.


Context and mechanics of the transactions

The Form 4 provides a sequence of movements: the settlement of performance share units generated shares at no cash cost to LaGorga; a parallel exercise of employee stock options converted option rights into 11,438 shares at a stated exercise price of $91.63; and a sale of the same count of shares at $135.00 each yielded $1.54 million in gross proceeds. A portion of shares was withheld to meet tax obligations at the rate applied in the filing.

Taken together, the filings and earnings announcement provide a snapshot of management compensation realization and current analyst sentiment following quarterly performance that exceeded expectations.

Risks

  • Valuation risk: InvestingPro analysis noted the stock is overvalued relative to its Fair Value and the company trades at a high P/E of 87.33 - this affects investor valuation assessments in the equity markets.
  • Near-term growth uncertainty: KeyBanc characterized initial growth as modest, citing first-half guidance around 4% topline growth, which could temper expectations for rapid revenue acceleration.
  • Market perception of insider activity: The CFO's sale occurred while the share price sits near its 52-week high, which could introduce short-term uncertainty among market participants regarding insider positioning.

More from Insider Trading

Biodesix CFO Disposes of 535 Shares as Company Posts Revenue Gains and EBITDA Profitability Feb 23, 2026 Ameris Bancorp Strategy Chief Withholds Shares to Cover Taxes After $550k Sale Feb 23, 2026 Samsara Legal Chief Sells $125,611 in Class A Shares as Stock Nears 52-Week Low Feb 23, 2026 Entegris General Counsel Disposes of $207K in Shares, Retains Significant Stake After PSU Settlement Feb 23, 2026 Entegris Strategy Chief Sells Shares as Stock Nears 52-Week Peak Feb 23, 2026